首页> 外文期刊>The Tohoku Journal of Experimental Medicine >A New Insight into Chronic Pancreatitis
【24h】

A New Insight into Chronic Pancreatitis

机译:对慢性胰腺炎的新洞察力

获取原文
获取原文并翻译 | 示例
       

摘要

Chronic pancreatitis (CP) is a pancreatic disease with poor prognosis characterized clinically by abdominal pain, morphologically by pancreatic stones/calcification, duct dilatation and atrophy, and functionally by pancreatic exocrine and endocrine insufficiency. CP is also known as a risk factor for the development of pancreatic cancer. CP has long been understood based on a fixed disease concept deduced from the clinical and morphological features of the end-stage disease. However, identification of causal genes for hereditary pancreatitis and success in the isolation and culture of pancreatic stellate cells have advanced the understanding of the underlying pathological mechanisms, the early-stage pathophysiology, and the mechanisms behind pancreatic fibrosis. These advances have led to moves aimed at improving patient prognosis through prevention of disease progression by early diagnosis and early therapeutic intervention. The strategy for preventing disease progression has included a proposal for diagnostic criteria for early CP and introduction of a new definition of CP in consideration of the pathological mechanisms. Our group has been committed deeply to these studies and has provided a large amount of information to the world.
机译:慢性胰腺炎(CP)是一种胰腺疾病,预后较差,其临床临床,通过胰腺结石/钙化,管道扩张和萎缩,以及通过胰腺外分泌和内分泌功能不全的功能性。 CP也称为胰腺癌发展的危险因素。仅基于从终级疾病的临床和形态学特征所推断的固定疾病概念来了解CP。然而,鉴定遗传性胰腺炎的因果基因和胰腺星状细胞的分离和培养的成功已经提出了对潜在的病理机制,早期病理生理学和胰纤维化背后的机制的理解。这些进展导致旨在通过预防早期诊断和早期治疗干预的疾病进展来改善患者预后的动作。预防疾病进展的策略包括提出诊断标准的初期CP诊断标准,并在考虑病理机制时引入CP的新定义。本集团已深入致力于这些研究,并为世界提供了大量信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号